Demonstrates improved brain tumour MRI segmentation in MRI data, suggesting enhanced precision and depth analysis.
Image segmentation demands a delicate balance between fine-grained spatial precision and global semantic reasoning, yet conventional U-shaped networks struggle to deliver both at once. Three architectural bottlenecks recur across existing designs: convolutional stacks whose effective receptive field expands only sub-linearly with depth; skip connections that indiscriminately forward low-level activations—including background noise—to the decoder; and a latent representation that is built solely from the deepest encoder stage, severing the link between shallow geometric cues and deep semantic abstractions. The proposed network integrates five tightly coupled modules: (1) a Squeeze-and-Excitation–enhanced residual encoder for channel-aware feature extraction; (2) a Transformer bottleneck augmented with 2D sinusoidal positional encoding to model unconstrained long-range dependencies; (3) an Atrous Spatial Pyramid Pooling block sampling the bottleneck at four dilation rates; (4) a Multi-Scale Fusion (MSF) pathway that propagates features from every encoder level into the bottleneck through learnable channel projection and spatial alignment; and (5) an attention-gated decoder in which a Convolutional Block Attention Module performs cascaded channel–spatial refinement at each upsampling step. Training is supervised at three output resolutions and guided by a composite objective combining binary cross-entropy, soft-Dice, focal, and a Laplacian boundary-aware loss. Beyond the architecture itself, we contribute a step-by-step forward-pass algorithm, a parameter count and asymptotic complexity analysis, and a theoretical analysis showing how cross-level fusion broadens the bottleneck’s effective receptive field. Evaluated on a public brain-tumour segmentation benchmark, PRISM-Net is trained end-to-end on real MRI data and assessed through qualitative segmentation results and a post-hoc SHapley Additive exPlanations (SHAP) attribution study; the latter serves as a qualitative sanity check, indicating that the model’s decisions are mildly localised to the lesion region rather than to background structures. A comprehensive quantitative comparison against competing architectures, a component-level ablation, and a cross-validation study form part of an ongoing benchmarking effort and are not claimed in this version.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: